Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, giving promising progress throughout a variety of clinical and industrial apps. With its structural similarity to The natural way derived human serum albumin, OsrHSA offers a safer, a lot more reputable alternate for therapeutic use,